| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 86.722 | 84.182 | 105.653 | 110.306 | 178.385 | 234.136 | 259.302 | 264.804 | 282.138 | 287.295 |
| Total Income - EUR | 88.848 | 85.910 | 108.771 | 113.253 | 181.249 | 331.459 | 259.315 | 265.170 | 307.711 | 287.409 |
| Total Expenses - EUR | 45.483 | 50.481 | 49.834 | 60.759 | 100.970 | 201.781 | 119.509 | 127.368 | 135.074 | 139.482 |
| Gross Profit/Loss - EUR | 43.364 | 35.429 | 58.938 | 52.494 | 80.280 | 129.677 | 139.806 | 137.802 | 172.637 | 147.926 |
| Net Profit/Loss - EUR | 36.426 | 33.711 | 55.943 | 51.364 | 78.467 | 126.781 | 137.278 | 135.445 | 169.627 | 140.597 |
| Employees | 2 | 2 | 2 | 2 | 3 | 5 | 5 | 4 | 3 | 3 |
Check the financial reports for the company - Naromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 92.857 | 89.910 | 91.146 | 180.766 | 170.865 | 156.346 | 154.672 | 204.201 | 227.756 | 198.645 |
| Current Assets | 11.019 | 10.557 | 49.882 | 6.275 | 37.614 | 52.894 | 41.631 | 31.949 | 81.057 | 118.069 |
| Inventories | 0 | 0 | 0 | 318 | 1.505 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 10.019 | 644 | 1.495 | 2.230 | 10.250 | 8.159 | 5.602 | 7.146 | 11.096 | 7.481 |
| Cash | 1.000 | 9.912 | 48.387 | 3.728 | 25.860 | 44.734 | 36.030 | 24.803 | 69.962 | 110.588 |
| Shareholders Funds | 40.864 | 38.104 | 93.402 | 134.456 | 168.173 | 188.398 | 179.993 | 188.993 | 216.533 | 234.244 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 63.012 | 62.363 | 47.625 | 52.585 | 40.306 | 20.841 | 16.310 | 47.157 | 92.280 | 82.470 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Naromed Srl